Association of chlamydia pneumoniae infection and carotid intima-media wall thickness in Japanese Americans

Circulation Journal

Volumn 70, Issue 7, 2006, Pages 815-819

  Jitsuiki, Kuniaki ^a   Yamane, Kiminori ^a   Nakajima, Masamitsu ^a   Nakanishi, Shuhei ^a   Tasaki, Naohito ^a   Watanabe, Hiroshi ^a   Kurihara, Hidemi ^b   Kohno, Nobuoki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Intima media wall thickness (IMT)

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6;

ADULT; AGE; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ASIAN AMERICAN; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; ECHOGRAPHY; FEMALE; GENDER; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR;

AGED; ARTERIOSCLEROSIS; ASIAN AMERICANS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMANS; IMMUNOGLOBULIN A; INTERLEUKIN-6; MALE; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA;

EID: 33745576886     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.815     Document Type: Article

References (40)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126.
2. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005; 352: 1685-1696.
3. Hong YJ, Jeong MH, Lim SY, Lee SR, Kim KH, Sohn IS, et al. Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting. Circ J 2005; 69: 1477-1483.
4. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, et al. Elevated levels of Interleukin-6 in unstable angina. Circulation 1996; 94: 874-877.
5. Thom DH, Grayston JT, Siscovick D, Way SP, Weiss NS, Daling JR, et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268: 68-72.
6. Gupta S, Camm AJ. Chlamydia pneumoniae and coronary heart disease. BMJ 1997; 314: 1778-1779.
7. 2 and high-sensitivity C-reactive protein to Chlamydia pneumoniae infection in acute coronary syndromes. Circ J 2004; 68: 628-633.
8. Saikku P, Mattila KJ, Nieminen MS, Huttunen JK, Leinonen M, Ekman MR, et al. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-986.
9. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992; 116: 273-278.
10. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Chlamydia pneumoniae IgG titers and coronary heart disease: Prospective study and meta-analysis. BMJ 2000; 321: 208-213.
11. Ridker PM, Kundsin RB, Stampfer MJ, Poulin S, Hennekens CH. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 1999; 99: 1161-1164.
12. Hugh SM, Matthias S, David C, Michael AM, Helmuth S. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation 1999; 100: 832-837.
13. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, et al. The role of carotid intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128: 262-269.
14. O'Leary DH, Polak JF, Kronmal RA, Burke GL, Manolio TA, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 14-22.
15. Watanabe H, Yamane K, Fujikawa R, Okubo M, Egusa G, Kohno N. Westernization of lifestyle markedly increases carotid intima-media wall thickness (IMT) in Japanese people. Atherosclerosis 2003; 166: 67-72.
16. Egusa G, Murakami F, Ito C, Matsumoto Y, Kado S, Okamura M, et al. Westernized food habits and concentrations of serum lipids in the Japanese. Atherosclerosis 1993; 100: 249-255.
17. Hara H, Egusa G, Yamakido M, Kawate R. The high prevalence of diabetes mellitus and hyperinsulinemia among the Japanese-Americans living in Hawaii and Los Angeles. Diabetes Res Clin Pract 1994; 24: 37-42.
18. Hara H, Egusa G, Yamakido M. Incidence of non-insulin dependent diabetes mellitus and its risk factors in Japanese-Americans living in Hawaii and Los Angeles. Diabet Med 1996; 13: 133-142.
19. Nakanishi S, Okubo M, Yoneda Y, Jitsuiki K, Yamane K, Kohno N. A comparison between Japanese-Americans living in Hawaii and Los Angeles and native Japanese: The impact of lifestyle westernization on diabetes mellitus. Biomed Pharmacother 2004; 58: 571-577.
20. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-475.
21. Warnick GR, Nguen T, Albers AA. Comparison of improved precipitation methods for quantification of high density lipoprotein cholesterol. Clin Chem 1985; 31: 217-218.
22. Miller WG, Waymack PP, Anderson FP, Ethridge SF, Jayne EC. Performance of four homogeneous direct methods for LDL-cholesterol. Clin Chem 2002; 48: 489-498.
23. Kishimoto T, Kubota Y, Matsushima T, Izutsu H, Matsumoto A, Soejima R, et al. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 1: Evaluation of ELISA kit using outer membrane complex. Kansenshogaku Zasshi 1996; 70: 821-829 (in Japanese, English abstract).
24. Kishimoto T, Kubota Y, Matsushima T, Izutsu H, Matsumoto A, Soejima R, et al. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2: Studies on clinical usefulness and serological diagnostic standards. Kansenshogaku Zasshi 1996; 70: 830-839 (in Japanese, English abstract).
25. Tasaki N, Nakajima M, Yamamoto H, Imazu M, Okimoto T, Otsuka M, et al. Influence of Chlamydia pneumoniae infection on aortic stiffness in healthy young men. Atherosclerosis 2003; 171: 117-122.
26. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999; 45: 2136-2141.
27. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406.
28. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus: Provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
29. Persson M, Carlberg B, Mjornal T, Asplund K, Bohlin J, Lindholm L. 1999 WHO/ISH Guidelines applied to a 1999 MONICA sample from northern Sweden. J Hypertens 2002; 20: 29-35.
30. Hata Y, Mabuchi H, Saito Y, Itakura H, Egusa G, Ito H, et al. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults. J Atheroscler Thromb 2002; 9: 1-27.
31. Sander D, Winbeck K, Klingelhöfer J, Etgen T, Conrad B. Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan Acute Respiratory) seropositivity. Circulation 2001; 103: 1390-1395.
32. Dechend R, Maass M, Gieffers, J Dietz R, Scheidereit C, Leutz A, et al. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression: A potential link to accelerated arteriosclerosis. Circulation 1999; 100: 1369-1373.
33. Rödel J, Woytas M, Groh A, Schmidt K, Hartmann M, Lehmann M, et al. Production of basic fibroblast growth factor and interleukin-6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect Immun 2000; 68: 3635-3641.
34. Bataille R, Klein B. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum 1992; 35: 982-984.
35. Johnston SC, Messina LM, Browner WS, Lawton MT, Morris C, Dean D. C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke 2001; 32: 2748-2754.
36. Kato A, Takita T, Maruyama, Y, Hishida A. Chlamydial infection and progression of carotid atherosclerosis in patients on regular haemodialysis. Nephrol Dial Transplant 2004; 19: 2539-2546.
37. Maeda N, Sawayama Y, Tatsukawa M, Shimizu C, Kashiwagi S, Hayashi J. Chlamydia pneumoniae seropositivity and early carotid atherosclerosis in a suburban Japanese population. Atherosclerosis 2002; 164: 313-319.
38. Melnick SL, Shalhar F, Folsom AR, Grayston JT, Sorie PD, Wang SP, et al. Past infection by Chlamydia pneumoniae Strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 1993; 95: 499-504.
39. Yamakido M, Nagasaki K, Hara H, Ogawa J, Nishimoto Y. Study on risk factors of ischemic heart disease in Japanese Americans and inhabitants of Hiroshima prefecture. ICMR Ann 1984; 4: 223-233.
40. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet 1997; 350: 430-436.